David A. Wenger, PhD

David A. Wenger, PhD

Contact Dr. Wenger

1020 Locust Street
Room 394
Philadelphia, PA 19107

(215) 955-1666
(215) 955-9554 fax

Most Recent Peer-reviewed Publications

  1. Rare Saposin A deficiency: Novel variant and psychosine analysis
  2. Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis
  3. A closer look at ARSA activity in a patient with metachromatic leukodystrophy
  4. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
  5. AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
  6. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
  7. GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB
  8. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State
  9. Krabbe disease: One Hundred years from the bedside to the bench to the bedside
  10. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease
  11. A patient with atypical multiple sulfatase deficiency
  12. Newborn screening for Krabbe disease in New York State: The first eight years' experience
  13. Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in twitcher mice
  14. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy
  15. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features
  16. Reprint of: Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases
  17. Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases
  18. Krabbe Disease: Globoid Cell Leukodystrophy
  19. Krabbe disease: Are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?
  20. Iminosugar-based galactoside mimics as inhibitors of galactocerebrosidase: SAR studies and comparison with other lysosomal galactosidases